Clinical trial
Tadalafil for the Treatment of Secondary Raynaud's Phenomenon
NCT00822354 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tadalafil for the Treatment of Secondary Raynaud's Phenomenon
- Lead sponsor
- Northwestern University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- April 30, 2010
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
raynaud